Clinical course and CSF amyloid β protein precursor having the site of application of the protease inhibitor (APPI) levels in patients with dementia of the Alzheimer type [1]

K. Urakami, K. Takahashi, A. Okada, T. Oshima, Y. Adachi, S. Nakamura, N. Kitaguchi, Y. Tokushima, S. Yamamoto, S. Tanaka

Research output: Contribution to journalLetter

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)59-60
Number of pages2
JournalDementia
Volume4
Issue number1
Publication statusPublished - 1993

All Science Journal Classification (ASJC) codes

  • Neuropsychology and Physiological Psychology
  • Geriatrics and Gerontology

Cite this

Urakami, K., Takahashi, K., Okada, A., Oshima, T., Adachi, Y., Nakamura, S., Kitaguchi, N., Tokushima, Y., Yamamoto, S., & Tanaka, S. (1993). Clinical course and CSF amyloid β protein precursor having the site of application of the protease inhibitor (APPI) levels in patients with dementia of the Alzheimer type [1]. Dementia, 4(1), 59-60.